This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Celanese (CE) Bumps Up Dividend Post Strong Q1 Earnings
by Zacks Equity Research
The dividend hike reflects Celanese's (CE) ability to generate strong cash flows.
Steel Dynamics (STLD) Q1 Earnings Top on Strong Demand
by Zacks Equity Research
Strong demand and improved pricing drove Steel Dynamics' (STLD) Q1 earnings.
Celanese (CE) Tops Q1 Earnings Estimates, Lifts FY18 View
by Zacks Equity Research
Strong gains across Engineered Materials and Acetyl Chain units drove Celanese's (CE) Q1 earnings.
Here's Why Huntsman (HUN) Should Be in Your Portfolio Now
by Zacks Equity Research
Based on its compelling prospects, we believe Huntsman (HUN) has plenty of upside potential.
Here's Why You Should Add Celanese (CE) to Your Portfolio
by Zacks Equity Research
Based on its compelling prospects, we believe Celanese (CE) has plenty of upside potential.
Eastman Chemical Up 35% in a Year: What's Behind the Rally?
by Zacks Equity Research
Forecast-topping earnings performance and upbeat 2018 outlook are contributing to a rally in Eastman Chemical's (EMN) price performance.
5 Reasons to Add U.S. Steel (X) Stock to Your Portfolio Now
by Zacks Equity Research
Based on its solid growth prospects and upbeat outlook, we believe U.S. Steel (X) has plenty of upside potential.
Is First Trust Materials AlphaDEX Fund (FXZ) a Hot ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXZ
4 Reasons to Add Century Aluminum (CENX) to Your Portfolio
by Zacks Equity Research
Based on its compelling prospects, we believe Century Aluminum (CENX) has plenty of upside potential.
Top Ranked Value Stocks to Buy for April 9th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 9th:
Is Eastman Chemical (EMN) a Good Stock for Value Investors?
by Zacks Equity Research
Let's see if Eastman Chemical Company (EMN) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Will Trade Tussle Take a Bite Out of US Petrochemical Boom?
by Anindya Barman
The Trump administration's actions to impose heavy tariffs on steel imports and threats of tariffs on U.S. chemical exports by China are detrimental to the American chemical industry.
Methanex (MEOH) Up 29% in 6 Months: What's Behind the Rally?
by Zacks Equity Research
Forecast-topping earnings performance and strong demand fundamentals for methanol have contributed to the rally in Methanex's (MEOH) shares.
Eastman Chemical (EMN) Poised on Acquisitions & Cost Cuts
by Zacks Equity Research
Eastman Chemical (EMN) should gain from cost-cutting actions, strategic acquisitions and debt reduction.
Steel Dynamics (STLD) Stock Up 23% in 6 Months: Here's Why
by Zacks Equity Research
Forecast-topping earnings performance, upbeat guidance and the Trump administration's trade actions on steel imports have contributed to the rally in Steel Dynamics' (STLD) shares.
5 Reasons to Add ArcelorMittal (MT) Stock to Your Portfolio
by Zacks Equity Research
Based on its compelling prospects, we believe ArcelorMittal (MT) has plenty of upside potential.
4 Reasons to Add Sherwin-Williams (SHW) to Your Portfolio Now
by Zacks Equity Research
Healthy growth prospects and upbeat outlook make Sherwin-Williams (SHW) an attractive investment option.
5 Dividend-Paying Chemical Stocks to Enrich Your Portfolio
by Zacks Equity Research
The new tax law is a major tailwind for dividend paying stocks in the chemical space.
5 Reasons to Add CF Industries (CF) Stock to Your Portfolio
by Zacks Equity Research
Based on its compelling prospects, we believe CF Industries (CF) has plenty of upside potential.
ArcelorMittal (MT) Up 22% in 6 Months: What's Driving the Stock?
by Anindya Barman
Strong earnings performance, upbeat outlook and the company's internal initiatives have contributed to a rally in ArcelorMittal's (MT) shares.
LyondellBasell Gets U.S. Antitrust Nod for A. Schulman Buyout
by Zacks Equity Research
The $2.25 billion acquisition doubles the size of LyondellBasell's (LYB) existing compounding business.
Eastman Chemical (EMN) Up 23% in 6 Months: What's Driving It?
by Zacks Equity Research
Solid Q4 results and upbeat 2018 outlook contributed to Eastman Chemical's (EMN) price performance. It should gain from cost-cutting actions, strategic acquisitions and debt reduction.
Here's Why You Should Add Methanex (MEOH) to Your Portfolio
by Zacks Equity Research
Healthy growth prospects and upbeat outlook make Methanex (MEOH) an attractive investment option.
Eastman Chemical Set to Raise Prices of Selective Products
by Zacks Equity Research
Eastman Chemical (EMN) is taking appropriate actions amid an escalated raw material pricing environment.
U.S. Silica (SLCA) to Divest Transload Assets for $75 Million
by Zacks Equity Research
The divestment is a continuation of U.S. Silica's (SLCA) strategy to utilize partners such as CIG Logistics to manage its transloading operations.